Compare DexCom, Inc. (DXCM) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Modine Manufacturing Company — how do they compare? DexCom, Inc. trades at $77.62 (market cap $28.06B), while Modine Manufacturing Company trades at $222.94 (market cap $12.32B). The key difference: DexCom, Inc. is far larger — about 2.3× Modine Manufacturing Company's market cap. Which is the better fit depends on your goals.
| DXCM | MOD | |
|---|---|---|
Market Cap | $28.06B | $12.32B |
Sector | Health | Technology |
52-Week High | $89.53 | $306.89 |
52-Week Low | $54.84 | $91.30 |
Enterprise Value | $27.03B | $12.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Modine (MOD) trades at $230.04, up 0.2% with a bearish technical signal despite strong analyst consensus. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 results pending. Financials show solid revenue growth to $2.58B in 2025 but declining profit margins. The stock faces technical headwinds with key support at $225 and resistance at $235.
Modine presents a mixed outlook with strong analyst support (76.9% buy ratings) and a $328.80 price target suggesting 43% upside. However, declining profit margins and bearish technical indicators create near-term uncertainty. The data center business expansion offers growth potential, but execution risks and competitive pressures remain key challenges for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
